Male breast cancer: A retrospective study comparing survival with female breast cancer

Oncology Letters

Volumn 4, Issue 4, 2012, Pages 642-646

  Baojiang, Li ^a   Tingting, Liu ^a   Gang, Li ^a   Li, Zhang ^b  

^a The Central Hospital of Tai'an   (China)

^b TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

Clinical characteristics; Female breast cancer; Male breast cancer; Prognosis; Therapy

Indexed keywords

HORMONE RECEPTOR;

ADULT; ARTICLE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER HORMONE THERAPY; CANCER LOCALIZATION; CANCER PROGNOSIS; CANCER SIZE; CANCER STAGING; CANCER SURVIVAL; CHI SQUARE TEST; CLINICAL STUDY; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HUMAN; KAPLAN MEIER METHOD; LOG RANK TEST; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; RETROSPECTIVE STUDY; STATISTICAL ANALYSIS;

EID: 84864699856     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2012.809     Document Type: Article

References (32)

1. Jemal A, Siegel R, Ward E, et al: Cancer statistics, 2008. CA Cancer J Clin 58: 71-96, 2008.
2. Giordano SH: Male breast cancer: it's time for evidence instead of extrapolation. Onkologie 31: 505-506, 2008.
3. Rosenblatt KA, Thomas DB, McTiernan A, et al: Breast cancer in men: aspects of familial aggregation. J Natl Cancer Inst 83: 849-854, 1991.
4. Marchal F, Salou M, Marchal C, et al: Men with breast cancer have same disease-specifi c and event-free survival as women. Ann Surg Oncol 16: 972-978, 2009.
5. Lynn K: Rare male breast cancer has similarities to female disease. MLO Med Lab Obs 42: 34-36, 2010.
6. Neumayer L, Schifftner TL, Henderson WG, et al: Breast cancer surgery in Veterans Affairs and selected university medical centers: results of the patient safety in surgery study. J Am Coll Surg 204: 1235-1241, 2007.
7. Anan K, Mitsuyama S, Nishihara K, et al: Breast cancer in Japanese men: does sex affect prognosis? Breast Cancer 11: 180-186, 2004.
8. Shuster JJ: Median follow-up in clinical trials. J Clin Oncol 9: 191-192, 1991.
9. Kaplan EL and Meier P: Nonparametric estimation from incomplete observations. J Am Statist Assoc 53: 457-481, 1958.
10. Giordano SH, Cohen DS, Buzdar AU, et al: Breast carcinoma in men: a population-based study. Cancer 101: 51-57, 2004.
11. Joshi MG, Lee AK, Loda M, et al: Male breast carcinoma: an evaluation of prognostic factors contributing to a poorer outcome. Cancer 77: 490-498, 1996.
12. Willsher PC, Leach IH, Ellis IO, et al: A comparison outcome of male breast cancer with female breast cancer. Am J Surg 173: 185-188, 1997.
13. El-Tamer MB, Komenaka IK, Troxel A, et al: Men with breast cancer have better disease-specific survival than women. Arch Surg 139: 1079-1082, 2004.
14. Anderson WF, Althuis MD, Brinton LA and Devesa SS: Is male breast cancer similar or different than female breast cancer? Breast Cancer Res Treat 83: 77-86, 2004.
15. Rudlowski C, Friedrichs N, Faridi A, et al: Her-2/neu gene amplification and protein expression in primary male breast cancer. Breast Cancer Res Treat 84: 215-223, 2004.
16. Tiezzi DG, Andrade JM, Ribeiro-Silva A, et al: HER-2, p53, p21 and hormonal receptors proteins expression as predictive factors of response and prognosis in locally advanced breast cancer treated with neoadjuvant docetaxel plus epirubicin combination. BMC Cancer 7: 36, 2007.
17. Bentel JM, Birrell SN, Pichering MA, et al: Androgen receptor agonist activity of the synthetic progestin, medroxyprogesterone acetate, in human breast cancer cells. Mol Cell Endocrinol 154: 11-20, 1999.
18. Auvinen A, Curtis RE and Ron E: Risk of subsequent cancer following breast cancer in men. J Natl Cancer Inst 94: 1330-1332, 2002.
19. Dong C and Hemminki K: Second primary breast cancer in men. Breast Cancer Res Treat 66: 171-172, 2001.
20. Hodgson NC, Button JH, Franceschi D, et al: Male breast cancer: is the incidence increasing? Ann Surg Oncol 11: 751-755, 2004.
21. Hemminki K, Scelo G, Boffetta P, et al: Sencond primary malignancies in patients with male breast cancer. Br J Cancer 92: 1288-1292, 2005.
22. Leibowitz SB, Garber JE, Fox EA, et al: Male patients with diagnoses of both breast cancer and prostate cancer. Breast J 9: 208-212, 2003.
23. Satram-Hoang S, Ziogas A and Anton-Culver H: Risk of second primary cancer in men with breast cancer. Breast Cancer Res 9: R10, 2007.
24. National Comprehensive Cancer Network: NCCN practice guidelines in oncology 2009. Available from: http://www.nccn.org/professionals/physician_gls/f_guidelines.asp. Accessed 30 May, 2010.
25. Giordano SH, Buzdar AU and Hortobagyi GN: Breast cancer in men. Ann Intern Med 137: 678-687, 2002.
26. Giordano SH, Perkins GH, Broglio K, et al: Adjuvant systemic therapy for male breast carcinoma. Cancer 104: 2359-2364, 2005.
27. Agrawal A, Ayantunde AA, Rampaul R and Robertson JF: Male breast cancer: a review of clinical management. Breast Cancer Res Treat 103: 11-21, 2007.
28. Nahleh Z and Girnius S: Male breast cancer: a gender issue. Nat Clin Pract Oncol 3: 428-437, 2006.
29. Fentiman IS, Fourquet A and Hortobagyi GN: Male breast cancer. Lancet 367: 595-604, 2006.
30. Mariotto A, Feuer EJ, Harlan LC, et al: Trends in use of adjuvant multi-agent chemotherapy and tamoxifen for breast cancer in the United States: 1975-1999. J Natl Cancer Inst 94: 1626-1634, 2003.
31. Ribeiro G and Swindell R: Adjuvant tamoxifen for male breast cancer (MBC). Br J Cancer 65: 252-254, 1992.
32. Anelli TF, Anelli A, Tran KN, et al: Tamoxifen administration is associated with a high rate of treatment-limiting symptoms in male breast cancer patients. Cancer 74: 74-77, 1994.